IRIS
NOBBIO, LUCILLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.594
Totale 5.594
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 5.594
Totale 5.594
Salva come PNG Salva come JPEG
Città #
Genova 4.286
Rapallo 777
Genoa 514
Bordighera 17
Totale 5.594
Salva come PNG Salva come JPEG
Nome #
Experimental Charcot-Marie-Tooth type 1A: A cDNA microarrays analysis 145
Does parkin play a role in the peripheral nervous system? A family report 143
Sphingomyelin as a myelin biomarker in CSF of acquired demyelinating neuropathies 136
Underexpression of messenger RNA for peripheral myelin protein 22 in hereditary neuropathy with liability to pressure palsies 132
Mycophenolate mofetil in dysimmune neuropathies: a preliminary study. 132
Early abnormalities in sciatic nerve function and structure in a rat model of Charcot-Marie-Tooth type 1A disease. 130
Alterations in the Arf6-regulated plasma membrane endosomal recycling pathway in cells overexpressing the tetraspan protein Gas3/PMP22 129
The diadenosine homodinucleotide P18 improves in vitro myelination in experimental Charcot-Marie-Tooth type 1A 129
Mifepristone (RU 38486) influences expression of glycoprotein Po and morphological parameters at the level of rat sciatic nerve: In vivo observations . 126
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. 123
Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease. 122
PMP22 transgenic dorsal root ganglia cultures show myelin abnormalities similar to those of human CMT1A. 121
Insulin treatment enhances expression of IGF-I in sural nerves of diabetic patients. 121
Hyccin, the Molecule Mutated in the Leukodystrophy Hypomyelination and Congenital Cataract (HCC), Is a Neuronal Protein. 117
Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations 113
Inherited Peripheral Neuropathies 112
Synaptopodin and 4 novel genes identified in primary sensory neurons. 111
Alternative Splicing in the Human PMP22 Gene: Implications in CMT1A Neuropathy 110
Mitichondrial dysfunction in experimental Charcot-marie-Tooth type 1° (CMTIA) neuropathy: a possible key factor for the axonal degeneration 108
Soluble Neuregulin1 is strongly up-regulated in the rat model of Charcot-Marie-Tooth 1A disease 108
Impaired expression of ciliary neurotrophic factor in Charcot-Marie-Tooth type 1A neuropathy 107
Axonal damage and demyelination in long-term dorsal root ganglia cultures from a rat model of Charcot-Marie-Tooth type 1A disease 106
Correlation among demyelination and axonal degeneration: a new trophic role for myelin sheath 96
Tyrosine kinase A-Nerve Growth Factor receptor is antigenically present in dystrophic neurites from a variety of conditions but not in Alzheimer's disease. 96
P2X7-mediated increased intracellular calcium causes functional derangement in Schwann cells from rats with CMT1A neuropathy 93
Neuroactive Steroid Levels in a transgenic rat model of CMT1A Neuropathy. 92
Oxydative phosphorylation in sciatic nerve myelin and its impairment in a model of dysmyelinating peripheral neuropathy 91
PMP22 messenger RNA levels in skin biopsies: Testing the effectiveness of a Charcot-Marie-Tooth 1A biomarker 90
P2X7 antagonists improve “in vitro” myelination in organotypic dorsal root ganglia (DRG) cultures from a rat model of CMT1A neuropathy 87
P2X7 antagonism in experimental CMT1A: a potential therapeutic strategy 87
P2X7 overexpression is responsible for the increased intracellular calcium and functional derangement in Schwann cells from rats with Charcot-Marie-Tooth type 1A neurophaty. 83
Diadenosine homodinucleotide products of ADP-ribosyl cyclases behave as modulators of the purinergic receptor P2X7. 82
Oxydative phosphorilation in sciatic nerve myelin and its impairment in a model of dysmyelinating peripheral neuropathy 81
Mitochondrial dysfunction in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy. 80
Energetic metabolism of myelinated axons: a new correlation among axonal degeneration, demyelination and energy supply. 80
Role of the P2X7 receptor in the altered calcium homeostasis of Schwann cells overexpressing peripheral myelin protein 22 80
Energetic disfunction in CMT1A: role of myelin and neuron mitochondria 78
A P2X7 antagonist improves muscle strength and motor distal amplitude in CMT1A rats: preliminary results from an in vivo trial 78
Ebf Genes In Peripheral Nerve Myelination 76
P2X7 antagonists improve “in vitro” myelination in organotypic dorsal root ganglia (DRG) cultures from a rat model of CMT1A neuropathy 76
The transcription factors EBF1 and EBF2 are positive regulators of myelination in Schwann cells 76
A P2X7 antagonist improves muscle strength and motor distal amplitude in CMT1A rats: preliminary results from an in vivo trial 75
Vitamin C and Charcot-Marie-Tooth 1A: Pharmacokinetic considerations 75
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol 73
Energy supply and demyelinising diseases: a new trophic role of myelin sheath. 72
P2X7 overexpression is responsible for the increased intracellular calcium and functional derangement in Schwann cells from rats with Charcot-Marie-Tooth type 1A neuropathy. 71
The diadenosine homodinucleotide P18 improvesin vitromyelination in experimental Charcot-Marie-Tooth type 1A 71
Effect of recombinant human nerve growth factor on cisplatin neurotoxicity in rats 67
Mitochondrial dysfunction in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy. 64
Mitochondrial dysfunction in experimental Charcot-Marie-Tooth type 1° (CMT1A) neuropathy. 63
Functional Characterization of Hyccin, a Novel Membrane Protein Involved in Central and Peripheral Myelination 62
Ebf genes' silencing impairs myelin formation 60
Exploiting Sphingo- and Glycerophospholipid Impairment to Select Effective Drugs and Biomarkers for CMT1A 58
Mitochondrial dysfunction in experimental Charcot-Marie-Tooth type 1° (CMT1A) neuropathy. 56
A P2X7 antagonist improves muscle strength and motor distal amplitude in CMT1A rats: preliminary results from an in vivo trial. 56
P2X7 RECEPTOR IMPLICATION IN CHARCOT-MARIE-TOOTH TYPE 1A (CMT1A) 56
Genetic Workup for Charcot–Marie–Tooth Neuropathy: A Retrospective Single-Site Experience Covering 15 Years 53
P2X7 TARGETING IMPROVES IN VITRO MYELINATION IN EXPERIMENTAL CHARCOT-MARIE-TOOTH TYPE 1A (CMT1A) 52
Inherited neuropathies. 50
Neuropatie di Charcot-Marie-Tooth: dalla patologia alla patogenesi 49
Role of the P2X7 receptor in the altered calcium homeostasis of Schwann cells overexpressing peripheral myelin protein 22 (PMP22) 49
null 48
Mitochondrial dysfunction in experimental Charcot-Marie-Tooth type 1° (CMT1A) neuropathy. 37
The SPTLC1 p.S331 mutation bridges sensory neuropathy and motor neuron disease and has implications for treatment 32
A novel mouse model of CMT1B identifies hyperglycosylation as a new pathogenetic mechanism 19
DEVELOPMENT AND VALIDATION OF A BIOMARKERS PANEL TO CAPTURE PATHOPHYSIOLOGICAL HETEROGENEITY OF GBS AND CIDP PATIENTS 14
Techniques for the standard histological and ultrastructural assessment of nerve biopsies 7
Selected items from the Charcot-Marie-Tooth (CMT) Neuropathy Score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients 4
Guillain barré syndrome of axonal type in a multple sclerosis patient: Fortuitous association or linked disorders? 3
Totale 5.679
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.873
article - articoli 12.490
book - libri 0
conference - conferenze 3.110
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 273
Totale 31.746
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019171 0 0 0 0 0 0 0 0 0 0 102 69
2019/20201.430 44 38 50 84 126 167 252 88 113 271 146 51
2020/2021353 24 37 20 51 18 25 22 34 33 30 29 30
2021/2022766 18 69 51 87 20 48 44 189 32 63 32 113
2022/2023902 75 84 7 84 176 133 5 82 141 6 97 12
2023/2024419 31 53 15 65 38 87 59 39 22 10 0 0
Totale 5.679